News Sentiment

REGN sentiment intelligence

Regeneron Pharmaceuticals, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 51 Balanced news tone 30 relevant articles
Exchange MEX Mexico
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 10835.99 Week of 17 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

85/100 classification confidence.

Company focus 30

directly relevant articles

Source quality 9

high-authority source matches

Trend context Trend inactive

+0.0% over one week, +3.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN

Market Reaction

Balanced read

51/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 85/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive 3.0% over four weeks
Fair value -24.2% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 14
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 30
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 14
Reuters 9
simplywall.st 3
PR Newswire 2
GlobeNewswire 1
Trefis 1

Event Lens

What the news is about

Classified themes
Market update 21
Earnings 6
Regulatory and legal 1
Analyst action 1
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 30